Danazol in the Treatment of Menorrhagia: The Effect of a 1 Month Induction Dose (200 mg) and 2 Month's Maintenance Therapy (200 mg, 100 mg, 50 mg or placebo)
RCT
OA: closed
CC0
⤵ 6 in-corpus citations
AI-generated summary
Danazol at 200 mg for induction and 200 mg for maintenance significantly reduced menstrual blood loss, with lower doses showing variable results and no sustained benefit after cessation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Summary: This paper highlights the difficulties of recruiting subjects to objective menstrual blood loss (MBL) studies. Such difficulties may explain the relative paucity of such studies in the literature. Eleven women with objectively assessed evidence of menorrhagia were treated for 1 month with an induction dose of 200 mg of danazol (Danocrine). Subsequently the women were randomly assigned to receive 50,100 or 200 mg of danazol or placebo for 2 months of maintenance dosing. Follow‐up with objective assessment of MBL was continued for 3 months after cessation of maintenance dosing. Danazol 200 mg as an induction dose significantly reduced MBL. The maintenance dose of 200 mg during the following 2 months produced a further decrease in MBL and in some cases amenorrhoea. The lower maintenance dosages of 50 mg and 100 mg were associated with a variable response. The study was unable to determine whether any beneficial effect of the maintenance dosages of danazol could be maintained following cessation of therapy since the study numbers had become too small. It appears, however, that there is unlikely to be any persisting benefit once therapy has ceased.
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (19)
- A comparative study of various dosages of danazol in the treatment of endometriosis via openalex
- Cholesterol, high density lipoprotein and danazol via openalex
- Comparison between mefenamic acid and danazol in the treatment of established menorrhagia via openalex
- Danazol: molecular, endocrine, and clinical pharmacology via openalex
- Dosage-related effects of danazol on sex hormone binding globulin and free and total androgen levels via openalex
- Dysfunctional uterine bleeding via openalex
- Effect of danazol on serum gonadotrophins and steroid hormone concentrations in women with menorrhagia via openalex
- Endometriosis 1990. Current treatment approaches via openalex
- Medical management of menorrhagia via openalex
- Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia via openalex
- Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo via openalex
- The effect of danazol on pulsatile gonadotropin secretion in women with endometriosis via openalex
- The medical management of menorrhagia via openalex
- Treatment of dysfunctional uterine bleeding with danazol via openalex
- doi:10.1016/0010-7824(77)90026-9 via openalex
- W6601518277 via openalex
- doi:10.1530/acta.0.0470444 via openalex
- doi:10.1080/00365516409060511 via openalex
- doi:10.3109/00365516409060511 via openalex
Cited by (5)
Source provenance
- openalex
- last seen: 2026-05-11T03:37:05.916399+00:00
License: CC0
· commercial use OK